SM
Sabby Management Portfolio holdings
AUM
$13M
This Quarter Return
+0.61%
1 Year Return
-26.95%
3 Year Return
-56.43%
5 Year Return
-61.92%
10 Year Return
-71.17%
AUM
$357M
AUM Growth
+$357M
(+25,059%)
Cap. Flow
+$144M
Cap. Flow
% of AUM
40.26%
Top 10 Holdings %
Top 10 Hldgs %
39.25%
Holding
232
New
62
Increased
19
Reduced
38
Closed
45
Top Buys
| 1 |
iShares Russell 2000 ETF
IWM
|
$24.7M |
| 2 |
AGN
Allergan plc
AGN
|
$14.4M |
| 3 |
ZGNX
Zogenix, Inc.
ZGNX
|
$11.5M |
| 4 |
MBLY
Mobileye N.V.
MBLY
|
$9.5M |
| 5 |
iShares 20+ Year Treasury Bond ETF
TLT
|
$7.23M |
Top Sells
| 1 |
ACHN
Achillion Pharmaceuticals, Inc.
ACHN
|
$8.78M |
| 2 |
SCTL
Societal CDMO, Inc. Common Stock
SCTL
|
$6.74M |
| 3 |
Adverum Biotechnologies
ADVM
|
$3.56M |
| 4 |
IOC
Interoil Corporation
IOC
|
$3.11M |
| 5 |
Merck
MRK
|
$2.9M |
Sector Composition
| 1 | Healthcare | 63.4% |
| 2 | Technology | 3.74% |
| 3 | Energy | 2.62% |
| 4 | Industrials | 1.07% |
| 5 | Consumer Staples | 0.86% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
THMO
26
DELISTED
ThermoGenesis Holdings, Inc. Common Stock
THMO
| $3.59M | 0.15% | 3,992,662 +290,967 | +8% | +$262K |
|
27
Viatris
VTRS
$12.3B
| $3.37M | 0.14% | +56,800 | New | +$3.37M |
|
28
Ascendis Pharma
ASND
$11.8B
| $3.37M | 0.14% | +194,023 | New | +$3.37M |
|
|
RIBT
29
DELISTED
RiceBran Technologies
RIBT
| $3.07M | 0.13% | 771,299 -27,901 | -3% | -$111K |
|
|
XTLB
30
XTL Biopharmaceuticals
XTLB
$10.8M
| $3.02M | 0.13% | +1,311,453 | New | +$3.02M |
|
|
AGTC
31
DELISTED
Applied Genetic Technologies Corporation
AGTC
| $3M | 0.12% | +150,000 | New | +$3M |
|
32
Arbutus Biopharma
ABUS
$711M
| $2.98M | 0.12% | +170,821 | New | +$2.98M |
|
|
IMUC
33
DELISTED
ImmunoCellular Therapeutics, Ltd.
IMUC
| $2.86M | 0.12% | +5,889,021 | New | +$2.86M |
|
34
Halozyme
HALO
$8.56B
| $2.74M | 0.11% | +191,621 | New | +$2.74M |
|
35
ProQR Therapeutics
PRQR
$237M
| $2.72M | 0.11% | 124,380 -128,703 | -51% | -$2.82M |
|
|
RXDX
36
DELISTED
Ignyta, Inc.
RXDX
| $2.58M | 0.11% | 259,032 -52,159 | -17% | -$519K |
|
|
CELG
37
DELISTED
Celgene Corp
CELG
| $2.56M | 0.11% | +22,225 | New | +$2.56M |
|
|
FWP
38
DELISTED
Forward Pharma A/S American Depositary Shares
FWP
| $2.55M | 0.11% | +90,060 | New | +$2.55M |
|
39
Opko Health
OPK
$1.1B
| $2.52M | 0.1% | +177,551 | New | +$2.52M |
|
|
TTOO
40
DELISTED
T2 Biosystems, Inc
TTOO
| $2.51M | 0.1% | 161,650 +27,841 | +21% | +$432K |
|
41
Cyclacel Pharmaceuticals
CYCC
$18.4M
| $2.49M | 0.1% | +2,760,717 | New | +$2.48M |
|
42
Abeona Therapeutics
ABEO
$350M
| $2.47M | 0.1% | 787,851 -202,744 | -20% | -$637K |
|
|
CRDC
43
DELISTED
CARDICA INC COM NEW (DE)
CRDC
| $2.43M | 0.1% | 3,863,723 +717,066 | +23% | +$452K |
|
|
ITCI
44
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $2.39M | 0.1% | +100,000 | New | +$2.39M |
|
|
ENDP
45
DELISTED
Endo International plc
ENDP
| $2.33M | 0.1% | +25,991 | New | +$2.33M |
|
|
APEN
46
DELISTED
Apollo Endosurgery, Inc.
APEN
| $2.32M | 0.1% | 939,690 -308,407 | -25% | -$762K |
|
|
47
Adverum Biotechnologies
ADVM
$64.6M
| $2.23M | 0.09% | 54,943 -87,860 | -62% | -$3.56M |
|
|
SCON
48
DELISTED
Superconductor Technologies Inc.
SCON
| $2.14M | 0.09% | +1,516,786 | New | +$2.14M |
|
49
Puma Biotechnology
PBYI
$254M
| $2.14M | 0.09% | 9,044 -9,816 | -52% | -$2.32M |
|
|
EPZM
50
DELISTED
Epizyme, Inc
EPZM
| $2.1M | 0.09% | +111,536 | New | +$2.1M |
|